This randomized clinical trial analyzes the effects of high-dose spironolactone vs usual care on N-terminal pro-B-type natriuretic peptide levels.
This simulation model study estimates the percentage of patients with atherosclerotic cardiovascular disease who would require proprotein convertase subtilisin/kexin type 9 inhibitor therapy when oral therapy to lower lipid levels is intensified first.
This study using data recorded in the Veterans Affairs Clinical Assessment, Reporting, and Tracking System for Cath Labs (CART-CL) program compares outcomes between black and white patients undergoing percutaneous coronary intervention in the Veterans Affairs hospitals system.
This study examines whether racial differences in survival after in-hospital cardiac arrest have changed over time and whether these differences could be explained by acute resuscitation survival, postresuscitation survival, and/or greater temporal improvement in survival at hospitals with higher proportions of black patients.
This study examines the predictive ability of coronary artery calcium score vs age for incident atherosclerotic cardiovascular disease and how risk prediction changes by adding coronary artery calcium score and removing only age from prediction models.
This cohort study investigates whether myocardial fibrosis is similarly prevalent in both those with heart failure with preserved ejection fraction (HFpEF) and those at risk for HFpEF, similarly associating with disease severity and outcomes.
This cross-sectional study uses NCDR CathPCI Registry data to examine the variation in contrast volume and acute kidney injury incidence among physicians who perform percutaneous coronary intervention.
This cohort study investigates the association between change in skin disease severity and change in vascular inflammation at 1 year and characterizes the impact of 1 year of anti–tumor necrosis factor therapy on vascular inflammation in patients with psoriasis.
This population-based study examines the use of and adherence to drugs from classes commonly used for therapy in patients with cardiovascular disease and diabetes.
This population-based study uses the Acute Coronary Treatment and Intervention Outcomes Network Registry to evaluate the prevalence of smoking cessation medication use among patients following myocardial infarction.
This clinical trial assesses ticagrelor administration and endothelial function and arterial stiffness in patients with coronary artery disease.
This Viewpoint summarizes treatment options for lowering low-density lipoprotein cholesterol levels, specifically the effects of adding additional drugs to statin therapy.
This Viewpoint summarizes the debate surrounding the LDL hypothesis and suggests next steps for better reducing atherosclerotic cardiovascular disease risk.
This Viewpoint discusses the outcomes of the Empagliflozin Removal of Excess of Glucose Outcome trial and the optential benefits of sodium-dependent glucose cotransporter 2 in treating heart failure.
This Editorial suggests that although the USPSTF awarded a C recommendation for the practice of behavioral counselling to promote healthful diet and physical activity for individuals at low risk for cardiovascular disease, such patient advice nonetheless has a good risk-benefit ratio.
This Special Communication examines the results of clinical trials to determine the benefit of sodium-glucose cotransporter 2 inhibitors on heart failure among patients with diabetes.
This review examines optimal medical therapy as secondary prevention for patients with known coronary artery disease.
A 35-year-old woman with a history of hypertension and chronic lymphocytic leukemia who underwent allogenic bone marrow transplant presents to an emergency department with shortness of breath and productive cough. What would you do next?
This article summarizes the guideline updates on indications for transcatheter aortic valve replacement.
Create a personal account or sign in to: